Harsh K Patel1, Romil Saxena2, Natalia Rush2, Suchi K Patel3, Chandra S Dasari4, Wadad Mneimneh5, Ariel Quickery2, Mahmoud A Rahal2, Lindsey Temnykh2, John DeWitt2, Mohammad Al-Haddad6. 1. Internal Medicine, Ochsner Clinic Foundation, New Orleans, LA, USA. 2. Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN, 46202-3082, USA. 3. Anand Institute of Management, Anand, Gujarat, India. 4. Division of Gastroenterology and Hepatology, Veterans Affairs Medical Center, Kansas City, MO, USA. 5. University of South Alabama Health College of Medicine, Mobile, AL, USA. 6. Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN, 46202-3082, USA. moalhadd@iu.edu.
Abstract
BACKGROUND AND AIMS: Data on comparative efficacy of various available endoscopic ultrasound-guided liver biopsy (EUS-LB) needles are limited. We sought to compare the performance of a novel Franseen-tip 22G fine-needle biopsy (FNB) device to that of 19G needle platforms for liver parenchyma. METHODS: Consecutive patients referred for EUS and suspected to have hepatic parenchymal disease underwent EUS-LB using different EUS needles and were included in this retrospective study. Two blinded expert liver pathologists independently reviewed and reported on: total number of tissue fragments, length of longest fragment, number of complete and incomplete portal tracts (CPT and IPT), and specimen adequacy. RESULTS: A 22G Franseen-tip needle (A) was used in 30 patients; 19G Tru-Cut needle (B) in 50 patients; 19G reverse beveled non-Tru-Cut needle (C) in 27 patients; and a 19G flexible non-Tru-Cut needle (D) in 28 patients. In the order of needles, A, B, C and D, > 10 tissue fragments were obtained in 100%, 6%, 82%, and 96% samples, the mean number of CPTs was 6.9; 3.0; 7.3; and 16.9, length of longest fragment was 3.8, 4. 7, 3.9, and 8.4 mm, and specimen adequacy was 66.7%, 46%, 82.1%, and 81.5%, respectively. A positive correlation was obtained between number of CPTs and length of longest fragment in samples accrued by 19G needles. CONCLUSION: EUS-LB specimens using 22G Franseen-tip needle appear highly fragmented, leading to inferior specimen adequacy compared to 19G non-Tru-Cut needles. We also report on using length of longest fragment as an additional criterion for specimen adequacy as it positively correlates with number of CPTs standard.
BACKGROUND AND AIMS: Data on comparative efficacy of various available endoscopic ultrasound-guided liver biopsy (EUS-LB) needles are limited. We sought to compare the performance of a novel Franseen-tip 22G fine-needle biopsy (FNB) device to that of 19G needle platforms for liver parenchyma. METHODS: Consecutive patients referred for EUS and suspected to have hepatic parenchymal disease underwent EUS-LB using different EUS needles and were included in this retrospective study. Two blinded expert liver pathologists independently reviewed and reported on: total number of tissue fragments, length of longest fragment, number of complete and incomplete portal tracts (CPT and IPT), and specimen adequacy. RESULTS:A 22G Franseen-tip needle (A) was used in 30 patients; 19G Tru-Cut needle (B) in 50 patients; 19G reverse beveled non-Tru-Cut needle (C) in 27 patients; and a 19G flexible non-Tru-Cut needle (D) in 28 patients. In the order of needles, A, B, C and D, > 10 tissue fragments were obtained in 100%, 6%, 82%, and 96% samples, the mean number of CPTs was 6.9; 3.0; 7.3; and 16.9, length of longest fragment was 3.8, 4. 7, 3.9, and 8.4 mm, and specimen adequacy was 66.7%, 46%, 82.1%, and 81.5%, respectively. A positive correlation was obtained between number of CPTs and length of longest fragment in samples accrued by 19G needles. CONCLUSION: EUS-LB specimens using 22G Franseen-tip needle appear highly fragmented, leading to inferior specimen adequacy compared to 19G non-Tru-Cut needles. We also report on using length of longest fragment as an additional criterion for specimen adequacy as it positively correlates with number of CPTs standard.
Authors: Asim Shuja; Ahmad Alkhasawneh; Andre Fialho; Andrea Fialho; Amal Shukri; Ciel Harris; Carmen Smotherman; Miguel Malespin; Silvio W de Melo Journal: Dig Liver Dis Date: 2019-01-22 Impact factor: 4.088
Authors: Babu P Mohan; Mohammed Shakhatreh; Rajat Garg; Suresh Ponnada; Douglas G Adler Journal: Gastrointest Endosc Date: 2018-10-31 Impact factor: 9.427
Authors: Yukihiro Nakanishi; Wadad S Mneimneh; Michael Sey; Mohammad Al-Haddad; John M DeWitt; Romil Saxena Journal: Am J Surg Pathol Date: 2015-07 Impact factor: 6.394
Authors: John Dewitt; Kathleen McGreevy; Oscar Cummings; Stuart Sherman; Julia K Leblanc; Lee McHenry; Mohammad Al-Haddad; Naga Chalasani Journal: Gastrointest Endosc Date: 2009-03 Impact factor: 9.427
Authors: Ferga C Gleeson; Amy C Clayton; Lizhi Zhang; Jonathan E Clain; Gregory J Gores; Elizabeth Rajan; Tom C Smyrk; Mark D Topazian; Kenneth K Wang; Maurits J Wiersema; Michael J Levy Journal: Clin Gastroenterol Hepatol Date: 2008-07-26 Impact factor: 11.382
Authors: Jonh J Pineda; David L Diehl; Chuan L Miao; Amitpal S Johal; Harshit S Khara; Ashok Bhanushali; Eric Z Chen Journal: Gastrointest Endosc Date: 2015-08-22 Impact factor: 9.427
Authors: Shiva Rangwani; Devarshi R Ardeshna; Khalid Mumtaz; Sean G Kelly; Samuel Y Han; Somashekar G Krishna Journal: World J Gastroenterol Date: 2022-07-28 Impact factor: 5.374